Skip to main content
Top
Published in: Clinical and Translational Oncology 7/2020

Open Access 01-07-2020 | Research Article

Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain

Authors: M. A. Segui, J. J. Cruz, E. Alba, J. Feliu, C. Jara, F. Rivera, A. Rodriguez Lescure, A. Lorenzo, M. Martin

Published in: Clinical and Translational Oncology | Issue 7/2020

Login to get access

Abstract

Purpose

The Spanish Society of Medical Oncology (SEOM, for its Spanish acronym) would like to attest to the relevance of training in Oncology as part of the undergraduate education in Medicine program and issue recommendations to improve said training, with the aim of responding better to the challenges that cancer poses to our society.

Materials and methods

The curricula of 42 schools of medicine were reviewed with interviews with at least one teaching medical oncologist from each faculty. The qualitative and opinion analysis was completed by means of an online questionnaire targeting lecturers, resident tutors, and residents in Medical Oncology (MO), enabling the detection of needs and areas for improvement at an organizational level and in terms of skill acquisition.

Results

While the number of medical schools with a specific, mandatory program in MO has grown by up to 90%, it has not been accompanied by an increase in independent programs. Instead, they largely consist of programs shared with other specialties (61% of the medical faculties). In most of the undergraduate education programs, Oncology contents are fragmented and approached from the perspective of each organ system.

Conclusions

Despite the positive evolution in recent years, the heterogeneity in Oncology contents during undergraduate education training continues to be remarkable. Cross-sectional programs with an integral vision, taught in the final years of undergraduate medical education would be desirable. Among the recommendations for improvement of training in Medical Oncology, the SEOM proposes that updated, theoretical content be incorporated and clinical practice in Medical Oncology departments be promoted.
Literature
1.
go back to reference SEOM. Las Cifras del Cáncer en España 2017. [Online] 2017. SEOM. Las Cifras del Cáncer en España 2017. [Online] 2017.
2.
go back to reference UICC/WHO. Undergraduate education in cancer in the European Region. 1981. UICC/WHO. Undergraduate education in cancer in the European Region. 1981.
3.
go back to reference Peckham M. A Curriculum in Oncology for Medical Students in Europe. Acta Oncol. 1989;28(1):141–7.CrossRef Peckham M. A Curriculum in Oncology for Medical Students in Europe. Acta Oncol. 1989;28(1):141–7.CrossRef
4.
go back to reference SEOM. Reunión de Docentes Universidades de España 2010. Córdoba: s.n., 2010. SEOM. Reunión de Docentes Universidades de España 2010. Córdoba: s.n., 2010.
5.
go back to reference SEOM. Formación de pregrado en Oncología. Una asignatura pendiente. 2013. SEOM. Formación de pregrado en Oncología. Una asignatura pendiente. 2013.
7.
go back to reference Real Decreto 1393/2007, de 29 de octubre, por el que se establece la ordenación de las enseñanzas universitarias oficiales. BOE-A-2007-18770. 2007. Real Decreto 1393/2007, de 29 de octubre, por el que se establece la ordenación de las enseñanzas universitarias oficiales. BOE-A-2007-18770. 2007.
8.
go back to reference Orden ECI/ 332/ 2008 de 13 de febrero de 2008, por la que se establecen los requisitos para la verificación de los títulos Universitarios oficiales que habiliten para el ejercicio de la profesión de médico. BOE-A-2008-2674. 2008. Orden ECI/ 332/ 2008 de 13 de febrero de 2008, por la que se establecen los requisitos para la verificación de los títulos Universitarios oficiales que habiliten para el ejercicio de la profesión de médico. BOE-A-2008-2674. 2008.
Metadata
Title
Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain
Authors
M. A. Segui
J. J. Cruz
E. Alba
J. Feliu
C. Jara
F. Rivera
A. Rodriguez Lescure
A. Lorenzo
M. Martin
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 7/2020
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02230-8

Other articles of this Issue 7/2020

Clinical and Translational Oncology 7/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine